SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-03-056303
Filing Date
2003-10-01
Accepted
2003-09-30 19:08:50
Documents
5
Period of Report
2003-09-30
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 GENOME THERAPEUTICS d8k.htm 8-K 15946
3 FORM OF WARRANT ISSUED BY THE COMPANY dex41.htm EX-4.1 45220
4 FORM OF SUBSCRIPTION AGREEMENT dex101.htm EX-10.1 53169
5 REGISTRATION RIGHTS AGREEMENT dex102.htm EX-10.2 59459
6 PRESS RELEASE DATED SEPTEMBER 30, 2003 dex991.htm EX-99.1 10170
  Complete submission text file 0001193125-03-056303.txt   186146
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-10824 | Film No.: 03918759
SIC: 2835 In Vitro & In Vivo Diagnostic Substances